AFP and neoplasm: Although tumor markers (CA19-9 and alpha-fetoprotein) were transiently elevated, the absence of malignant masses on imaging and the subsequent normalization of CA19-9 levels following treatment led to the exclusion of malignancy-associated jaundice.